Business Context and Reporting Period
Company: LightPath Technologies, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2001 (First Quarter of Fiscal 2002)
Business Overview: The Company manufactures collimators, isolators, precision molded aspherical optics, and GRADIUM glass lenses for the telecommunications and traditional optics markets. Operations include the acquired Geltech, Inc. business, which provides diffraction gratings and waveguides.
Key Financial Metrics
| Metric | Q1 2002 (Sep 30, 2001) | Q1 2001 (Sep 30, 2000) |
|---|---|---|
| Total Revenues | $3,458,046 | $3,064,939 |
| Cost of Sales | $3,113,767 | $1,724,774 |
| Gross Margin | 10.0% | 43.7% |
| Operating Loss | $(11,065,974) | $(17,768,798) |
| Net Loss | $(10,356,251) | $(16,938,733) |
| Net Loss Per Share (Basic/Diluted) | $(0.54) | $(0.93) |
| Cash and Cash Equivalents | $24,986,816 | $45,868,606 |
| Working Capital | $30,468,618 | Filing text does not provide clear prior period working capital value |
| Backlog | $16.5 million | Filing text does not provide clear prior period backlog value |
Liquidity: The Company holds approximately $25.0 million in cash and cash equivalents. Net cash used in operating activities was $3.3 million for the quarter.
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased 13% to $3.5 million, driven by a 456% increase in finished lens sales ($1.1 million growth), partially offset by a 26% decline in telecom product sales.
- Margin Compression: Gross margin collapsed from 43.7% to 10.0%. Cost of sales rose to 90% of product sales due to underutilization of manufacturing facilities, lower margins on small volume qualification runs, and the elimination of unprofitable traditional optic products.
- Operating Expenses: Selling, general, and administrative (SG&A) expenses increased by $0.4 million, primarily due to $1.2 million accrued for legal fees and a proposed litigation settlement. Research and development costs increased by $0.7 million.
- Non-Cash Charges: The current quarter included $2.7 million in amortization of goodwill/intangibles and $2.8 million in stock-based compensation. The prior year quarter included a $9.1 million non-recurring charge for acquired in-process research and development.
- Net Loss Improvement: Net loss decreased by approximately $6.6 million compared to the prior year, largely due to the absence of the $9.1 million in-process R&D charge recorded in the prior year.
Guidance, Outlook, and Risks
- Outlook: Management anticipates improved cost of sales in the second quarter following a 37% reduction in manufacturing personnel and the closure of the Auburn, California facility. However, economic conditions may result in pricing pressure in fiscal 2002.
- Backlog Status: The $16.5 million backlog includes purchase orders where shipments have been pushed out past original delivery dates; revised dates have not been provided by customers, making future revenue recognition timing uncertain.
- Legal Contingencies:
- Class E Stock Litigation: A settlement is probable. The Company accrued $1 million at September 30, 2001. Shareholders may elect cash ($0.40/share) or options. Maximum cash exposure is estimated at $1.6 million.
- Texas Action: The Company is vigorously defending against a lawsuit regarding Class E stock issuance. Legal fees of $200,000 were incurred in the quarter. An insurance claim was filed, but one insurer involved was declared insolvent.
- Accounting Changes: The Company is evaluating the impact of new FASB Statements 141 and 142 regarding goodwill and intangible assets, which may require impairment testing and reclassification upon adoption in fiscal 2002/2003.
Investor Verification Checklist
- Backlog Realization: Verify the status of the $16.5 million backlog, specifically the portion with delayed shipment dates and the concentration of 55% of the telecom backlog with Agere Systems, Inc.
- Litigation Settlement: Confirm the final terms of the Class E stock settlement and the actual cash outflow versus option issuance.
- Insurance Recovery: Monitor the status of the insurance claim related to the Texas Action lawsuit, given the insolvency of one of the responsible carriers.
- Margin Recovery: Assess whether the reduction in manufacturing staff and facility closures will successfully restore gross margins in subsequent quarters.
- Goodwill Impairment: Review future filings for the impact of FASB Statement 142 on the $5.2 million goodwill and $23 million in intangible assets.